Glaukos (GKOS) Income from Non-Controlling Interests (2014 - 2015)
Glaukos (GKOS) reported Income from Non-Controlling Interests of -$584000.0 for Q2 2015, down 39.05% year-over-year from -$958125.0 in Q2 2014, and down 17.74% on a QoQ basis from -$496000.0 in Q1 2015.
Glaukos (GKOS) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$584000.0 in Q2 2015.
- Quarterly Income from Non-Controlling Interests fell 39.05% year-over-year to -$584000.0 in Q2 2015, while the trailing twelve-month figure through Dec 2015 was -$1.1 million (changed N/A YoY) and the FY2015 annual result came in at -$1.1 million, up 44.07% from the prior year.
- Income from Non-Controlling Interests fell to -$584000.0 in Q2 2015 per GKOS's latest filing, from -$496000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$420000.0 in Q2 2014 and bottomed at -$647000.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -584,000.00 |
| Mar 31, 2015 | -496,000.00 |
| Dec 31, 2014 | -647,000.00 |
| Sep 30, 2014 | -482,000.00 |
| Jun 30, 2014 | -420,000.00 |